MAGNANI, LUCA
MAGNANI, LUCA
Dipartimento di Oncologia ed Emato-Oncologia
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
2024 D. Rosano, E. Sofyali, H. Dhiman, C. Ghirardi, D. Ivanoiu, T. Heide, A. Vingiani, A. Bertolotti, G. Pruneri, E. Canale, H.F. Dewhurst, D. Saha, N. Slaven, I. Barozzi, T. Li, G. Zemlyanskiy, H. Phillips, C. James, B. Győrffy, C. Lynn, G.D. Cresswell, F. Rehman, R. Noberini, T. Bonaldi, A. Sottoriva, L. Magnani
A Functional Survey of the Regulatory Landscape of Estrogen Receptor–Positive Breast Cancer Evolution
2024 I. Barozzi, N. Slaven, E. Canale, R. Lopes, I.A.M. Barbosa, M. Bleu, D. Ivanoiu, C. Pacini, E. Mensa', A. Chambers, S. Bravaccini, S. Ravaioli, B. Gyorffy, M.V. Dieci, G. Pruneri, G.G. Galli, L. Magnani
Cancer Evolution: A Multifaceted Affair
2024 G. Ciriello, L. Magnani, S.J. Aitken, L. Akkari, S. Behjati, D. Hanahan, D.A. Landau, N. Lopez-Bigas, D.G. Lupianez, J.-. Marine, A. Martin-Villalba, G. Natoli, A.C. Obenauf, E. Oricchio, P. Scaffidi, A. Sottoriva, A. Swarbrick, G. Tonon, S. Vanharanta, J. Zuber
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)
2023 L. Ferrando, A. Vingiani, A. Garuti, C. Vernieri, A. Belfiore, L. Agnelli, G. Dagrada, D. Ivanoiu, G. Bonizzi, E. Munzone, L. Lippolis, M. Dameri, F. Ravera, M. Colleoni, G. Viale, L. Magnani, A. Ballestrero, G. Zoppoli, G. Pruneri
The co-evolution of the genome and epigenome in colorectal cancer
2022 T. Heide, J. Househam, G.D. Cresswell, I. Spiteri, C. Lynn, M. Mossner, C. Kimberley, J. Fernandez-Mateos, B. Chen, L. Zapata, C. James, I. Barozzi, K. Chkhaidze, D. Nichol, V. Gunasri, A. Berner, M. Schmidt, E. Lakatos, A.-. Baker, H. Costa, M. Mitchinson, R. Piazza, M. Jansen, G. Caravagna, D. Ramazzotti, D. Shibata, J. Bridgewater, M. Rodriguez-Justo, L. Magnani, T.A. Graham, A. Sottoriva
Phenotypic plasticity and genetic control in colorectal cancer evolution
2022 J. Househam, T. Heide, G.D. Cresswell, I. Spiteri, C. Kimberley, L. Zapata, C. Lynn, C. James, M. Mossner, J. Fernandez-Mateos, A. Vinceti, A.-. Baker, C. Gabbutt, A. Berner, M. Schmidt, B. Chen, E. Lakatos, V. Gunasri, D. Nichol, H. Costa, M. Mitchinson, D. Ramazzotti, B. Werner, F. Iorio, M. Jansen, G. Caravagna, C.P. Barnes, D. Shibata, J. Bridgewater, M. Rodriguez-Justo, L. Magnani, A. Sottoriva, T.A. Graham
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition
2021 F. De Santis, G. Fuca, D. Schadendorf, A. Mantovani, L. Magnani, M. Lisanti, S. Pettitt, M. Bellone, G. Del Sal, S. Minucci, A. Eggermont, P. Bruzzi, S. Bicciato, P. Conte, R. Noberini, J. Hiscott, F. De Braud, M. Del Vecchio, M. Di Nicola
Ultra-deep multigene profiling of matched primary and metastatic hormone receptor positive breast cancer patients relapsed after adjuvant endocrine treatment reveals novel aberrations in the estrogen receptor pathway
2020 G. Zoppoli, A. Garuti, A. Belfiore, G. Bonizzi, L. Ferrando, A. Vingiani, M. Colleoni, E. Munzone, L. Magnani, G. Viale, A. Ballestrero, G. Pruneri
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy
2019 S. Hong, T. Chan, Y. Lombardo, G. Corleone, N. Rotmensz, G. Pruneri, K. Mcewen, R. Coombes, I. Barozzi, L. Magnani
Extensive and systematic rewiring of histone post-translational modifications in cancer model systems
2018 R. Noberini, D. Osti, C. Miccolo, C. Richichi, M. Lupia, G. Corleone, S.-. Hong, P. Colombo, B. Pollo, L. Fornasari, G. Pruneri, L. Magnani, U. Cavallaro, S. Chiocca, S. Minucci, G. Pelicci, T. Bonaldi
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
2018 D.K. Patten, G. Corleone, B. Győrffy, Y. Perone, N. Slaven, I. Barozzi, E. Erdős, A. Saiakhova, K. Goddard, A. Vingiani, S. Shousha, L.S. Pongor, D.J. Hadjiminas, G. Schiavon, P. Barry, C. Palmieri, R.C. Coombes, P. Scacheri, G. Pruneri, L. Magnani
Enhancers mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
2017 D.K. Patten, G. Corleone, B. Gy?rffy, E. Erd?s, A. Saiakhova, K. Goddard, A. Vingiani, S. Shousha, L.S. Pongor, D.J. Hadjiminas, G. Schiavon, P. Barry, C. Palmieri, R.C. Coombes, P. Scacheri, G. Pruneri, L. Magnani
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
2017 L. Magnani, G. Frige, R.M. Gadaleta, G. Corleone, S. Fabris, M.H. Kempe, P.J. Vershure, I. Barozzi, V. Vircillo, S.P. Hong, Y. Perone, M. Saini, A. Trumpp, G. Viale, A. Neri, S. Ali, M.A. Colleoni, G. Pruneri, S. Minucci
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation
2015 M. Faronato, V.T. Nguyen, D.K. Patten, Y. Lombardo, J.H. Steel, N. Patel, L. Woodley, S. Shousha, G. Pruneri, R.C. Coombes, L. Magnani